COVID WENT.HEALTHCARE STAYED

A look at the company’s revenue footprints and business strides since 2021 shows that health and products are its new strong lanes now.

- 

The mark of a good runner is speed. But it has to be underlined with the consistency of performance. Whether in a car, or on its own feet, a good racer never switches lanes too abruptly.

That's exactly what we see when we look at the tracks that Cognizant has been running in. The last few months exhibit a clear commitment to, and gains from, good laps done in circuits that have become particularly pronounced after the pandemic. That's why you would notice spotlight on health, on product-related revenue, on client wins in insurance vertical - as some examples of a new bend in the road.

Let's start with some fresh-off-the-press numbers. Its second Quarter 2022 financial results show that this professional services company attained a revenue of $4.9 billion. This performance was in some correspondence to what the company had earmarked during the previous quarter when it noted in its guidance that Second quarter revenue is expected to be $4.90-$4.94 billion. The Full-year 2022 revenue as expected in this guidance was noted at $19.8-$20.2 billion.

That dartboard was, more or less, achieved during this quarter. Key things that catch your eye when you look at this pie is the company's continued momentum in expanding the healthcare and product slices.

Products and Resources revenue, interestingly, showed a notable jump of 8.1 per cent year-over-year with strong support from automotive, logistics, retail and consumer goods clients. Financial Services revenue climbed at less impressive pace - at 2.7 per cent year-over-year but claimed to have some sunny drivers from U.S. regional banking clients, strength in the United Kingdom and solid performance within insurance.

KEY WINS

• Here's the string of main deals won this year and some months before that. Pharma and insurance seem to be recurring themes in this list.